The healthcare industry has been continually witnessing a wave of strategic mergers and acquisitions, which could bring in major transformations in the spectrum of healthcare business. Post multiple series of consolidation between the pharmacy benefits managers and health insurers last year, biotech companies have been flourishing in the healthcare space as they have evolved as …
Category Archives: Healthcare Trends
Graphene based Implant will Deepen the Understanding of Brain at Low Frequencies
Researchers in Barcelona have found a new grapheme based implant to map the brains activity below 0.1 Hz of frequency. The prototype created at Barcelona Microelectronics Institute will help in understanding the brains activity exponentially. For decades researchers were using electrode arrays to map the activity in the various parts of the brain. The electrode …
Continue reading “Graphene based Implant will Deepen the Understanding of Brain at Low Frequencies”
Medical Manufacturers are Exploiting a Grandfathering Clause in the Regulation to Postpone Implementation of EU’s New Rules
As Implant Files, an investigation by International Consortium of Investigative Journalists (ICIJ), have exposed failure of medical regulators to test faulty medical implants and save lives, companies are using an exemption clause to escape from EU’s new rules. The May 2020 Deadline for manufacturers who test medical devices to comply with recertification norms has led …
Nuvo Pharmaceuticals Completes Previously Announced Acquisition of Aralez’ Revenue-Generating Products
Nuvo Pharmaceuticals, a Canadian healthcare firm, has completed the acquisition of a portfolio of more than 20 revenue-generating products of Aralez Pharmaceuticals. Earlier, the news of Nuvo having a conference call/audio webcast on January 2, 2019, at 8:30 a.m. EST was released. The call was about providing the details of the transaction, Aralez’s key products, …
Nuvo Pharmaceuticals Completes Previously Announced Acquisition of Aralez’ Revenue-Generating Products
Nuvo Pharmaceuticals, a Canadian healthcare firm, has completed the acquisition of a portfolio of more than 20 revenue-generating products of Aralez Pharmaceuticals. Earlier, the news of Nuvo having a conference call/audio webcast on January 2, 2019, at 8:30 a.m. EST was released. The call was about providing the details of the transaction, Aralez’s key products, …
Medical Manufacturers are Exploiting a Grandfathering Clause in the Regulation to Postpone Implementation of EU’s New Rules
As Implant Files, an investigation by International Consortium of Investigative Journalists (ICIJ), have exposed failure of medical regulators to test faulty medical implants and save lives, companies are using an exemption clause to escape from EU’s new rules. The May 2020 Deadline for manufacturers who test medical devices to comply with recertification norms has led …
Graphene based Implant will Deepen the Understanding of Brain at Low Frequencies
Researchers in Barcelona have found a new grapheme based implant to map the brains activity below 0.1 Hz of frequency. The prototype created at Barcelona Microelectronics Institute will help in understanding the brains activity exponentially. For decades researchers were using electrode arrays to map the activity in the various parts of the brain. The electrode …
Continue reading “Graphene based Implant will Deepen the Understanding of Brain at Low Frequencies”
Intel and GE Healthcare’s New AI-based Solution Will Help Reduce Delay in Medical Diagnosis
Intel and GE Health’s, two of the biggest players in the digital healthcare sector, have in a collaborative project shown promises to significantly reduce the time between imaging and medical diagnosis. The new technology will harness the Intel Distribution of OpenVINO Toolkit which runs on Intel’s x-ray systems to help prioritizing and optimizing patient care. …
Bristol-Myers Agrees on Acquisition of Celgene; Healthcare ETFs Remains the Key Focus
The healthcare industry has been continually witnessing a wave of strategic mergers and acquisitions, which could bring in major transformations in the spectrum of healthcare business. Post multiple series of consolidation between the pharmacy benefits managers and health insurers last year, biotech companies have been flourishing in the healthcare space as they have evolved as …
Governmental Policy Shift Along with Changing Landscape Threatens Chinese Drug maker’s Generic-based Business Model
Chinese drug maker’s stocks plunged by $46 billion in December 2018. Chinese government is planning a shift in its drug pricing policy by undertaking bulk procurement of drugs as part of its new program. The move is significant as it will bring down prices of drugs as a major step towards universal and cheaper access …